(Updated - February 21, 2024 7:40 AM EST)

Repligen (NASDAQ: RGEN) reported Q4 EPS of $0.33, in-line with the analyst estimate of $0.33. Revenue for the quarter came in at $155.7 million versus the consensus estimate of $155.38 million.

GUIDANCE:

Repligen sees 2024 EPS of $1.42-$1.49, versus the consensus of $1.77. Repligen sees 2024 revenue of $620-650 million, versus the consensus of $660.7 million.

For earnings history and earnings-related data on Repligen (RGEN) click here.

Earnings Guidance